
Kevin Hern
RHouseRepresentative · Oklahoma
B
Sold up to $50,000 of Boston Scientific (BSX)
Trade dated Oct 28, 202519 days to disclose
BSX since the sale
-51.6%
S&P 500, same window
+10.2%
▼ BSX trailed the S&P 500 by 61.8 points since the sale
Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.
⚑ Committee jurisdiction
Kevin Hern sits on Ways and Means, which oversees the Healthcare sector. This trade fell in that sector while Kevin Hern held the seat. STOCK Act trades are legal; this is a structural overlap on the public record.
On the public record around this trade
Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.
- Aug 15, 2025LegislationHealthcare sector
- Sep 10, 2025LegislationHealthcare sector
- Sep 17, 2025LegislationHealthcare sector
- Sep 18, 2025LegislationHealthcare sector
- Sep 19, 2025Floor voteResult: Failed
- Sep 19, 2025Floor voteResult: Passed
- Oct 28, 2025LegislationHealthcare sector
- Oct 28, 2025TradeSold up to $50,000 of BSX
- Nov 13, 2025Floor voteResult: Passed
- Nov 16, 2025DisclosureDisclosed the tradePublic filing
- Nov 20, 2025Floor voteResult: Passed
- Dec 1, 2025Floor voteResult: Passed
- Dec 10, 2025CommitteePutting Families First: Strengthening CHAMPVA for Survivors and Dependents
Get an alert the moment Kevin Hern files the next one
Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.